Valid for Submission
C54.9 is a billable code used to specify a medical diagnosis of malignant neoplasm of corpus uteri, unspecified. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C54.9 might also be used to specify conditions or terms like adenosarcoma of corpus uteri, adenosarcoma of uterus, carcinofibroma of corpus uteri, carcinoma of corpus uteri, carcinosarcoma of corpus uteri, carcinosarcoma of uterus, etc
The code C54.9 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: corpus uteri or uterus, uteri, uterine body or uterus, uteri, uterine cornu or uterus, uteri, uterine corpus .
| ICD-10: | C54.9 |
| Short Description: | Malignant neoplasm of corpus uteri, unspecified |
| Long Description: | Malignant neoplasm of corpus uteri, unspecified |
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C54.9 are found in the index:
- - Müllerian mixed tumor
- - unspecified site - C54.9
- - Tumor - See Also: Neoplasm, unspecified behavior, by site;
- - Müllerian, mixed
- - unspecified site - C54.9
- - Müllerian, mixed
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for females only - Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, this code applies to FEMALES only .
Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Adenosarcoma of corpus uteri
- Adenosarcoma of uterus
- Carcinofibroma of corpus uteri
- Carcinoma of corpus uteri
- Carcinosarcoma of corpus uteri
- Carcinosarcoma of uterus
- Leiomyosarcoma of corpus uteri
- Leiomyosarcoma of uterus
- Malignant germ cell neoplasm of corpus uteri
- Malignant neoplasm of body of uterus
- Malignant neoplasm of cornu of corpus uteri
- Malignant neoplasm of corpus uteri, excluding isthmus
- pM1
- pN1
- Primary malignant neoplasm of body of uterus
- Primitive neuroectodermal tumor
- Primitive neuroectodermal tumor of corpus uteri
- pT1
- pT1b
- pT1c
- pT1c category
- pT2
- pT2a
- pT2b
- pT3
- pT3a
- pT3a
- pT3b
- pT4
- Rhabdomyosarcoma of corpus uteri
- Squamous cell carcinoma of corpus uteri
- Undifferentiated carcinoma of corpus uteri
Diagnostic Related Groups
The ICD-10 code C54.9 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2019 through 09/30/2020.
- 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
- 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
- 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
- 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
- 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
- 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC
Convert C54.9 to ICD-9
- 182.0 - Malig neo corpus uteri (Approximate Flag)
Code Classification
Code History
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set) - FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020